You are here

Adamas to Present at Two Upcoming Investor Conferences

EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, today announced that Gregory T. Went, Ph.D., the Company’s Founder, Chairman and Chief Executive, is scheduled to present at the following two investor conferences:
Wednesday, February 20, 2019 - 16:50